Opt-out Preferences

We use third-party cookies that help us analyze how you use this website, store your preferences, and provide the content and advertisements that are relevant to you. However, you can opt out of these cookies by checking "Do Not Sell My Personal Information" and clicking the "Save My Preferences" button. Once you opt out, you can opt in again at any time by unchecking "Do Not Sell My Personal Information" and clicking the "Save My Preferences" button.

Do Not Sell My Personal Information
Blog
View all blogs

HMA analysis of the 2021 Medicare Advantage landscape and mandatory Medicare radiation oncology and ESRD treatment choices innovation models

This week, our In Focus section reviews two recent Medicare developments from the Centers for Medicare & Medicaid Services (CMS). On September 24, 2020, CMS released the Medicare Advantage (MA) and Part D landscape files for the 2021 plan year. These files include information on MA and Part D offerings, including plan types and premiums. Earlier this month, CMS also released a final rule implementing two new mandatory payment models addressing radiation oncology and end-stage renal disease (ESRD).

HMA’s preliminary analysis of the 2021 MA landscape can be found here.

HMA’s summary of the finalized ESRD and Radiation Oncology models, which are scheduled to go into effect January 2021, can be found here.

Ready to talk?